Randomized controlled trials of low molecular weight heparin in non-mild acute pancreatitis : A systemic review and meta-analysis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:221 |
|---|---|
| Enthalten in: |
Thrombosis research - 221(2023) vom: 15. Jan., Seite 26-29 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
He, Kun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9005-49-6 |
|---|
| Anmerkungen: |
Date Completed 30.12.2022 Date Revised 12.01.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.thromres.2022.11.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349493499 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349493499 | ||
| 003 | DE-627 | ||
| 005 | 20231226042743.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.thromres.2022.11.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1164.xml |
| 035 | |a (DE-627)NLM349493499 | ||
| 035 | |a (NLM)36436442 | ||
| 035 | |a (PII)S0049-3848(22)00460-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a He, Kun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Randomized controlled trials of low molecular weight heparin in non-mild acute pancreatitis |b A systemic review and meta-analysis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.12.2022 | ||
| 500 | |a Date Revised 12.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Hemorrhage | |
| 650 | 4 | |a Low molecular weight heparin | |
| 650 | 4 | |a Pancreatitis | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Systemic review | |
| 650 | 4 | |a Thrombosis | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Heparin |2 NLM | |
| 650 | 7 | |a 9005-49-6 |2 NLM | |
| 650 | 7 | |a Heparin, Low-Molecular-Weight |2 NLM | |
| 700 | 1 | |a Zhang, Yuelun |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Kai |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Zhengyang |e verfasserin |4 aut | |
| 700 | 1 | |a Gong, Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Shu, Huijun |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Dong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Thrombosis research |d 1974 |g 221(2023) vom: 15. Jan., Seite 26-29 |w (DE-627)NLM000010839 |x 1879-2472 |7 nnns |
| 773 | 1 | 8 | |g volume:221 |g year:2023 |g day:15 |g month:01 |g pages:26-29 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.thromres.2022.11.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 221 |j 2023 |b 15 |c 01 |h 26-29 | ||